NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.8400
-0.0010 (-0.12%)
At close: Dec 23, 2025, 4:00 PM EST
0.8501
+0.0101 (1.20%)
After-hours: Dec 23, 2025, 5:50 PM EST
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $21.04 million as of December 23, 2025. Its market cap has decreased by -2.33% in one year.
Market Cap
21.04M
Enterprise Value
20.87M
1-Year Change
-2.33%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $21.04M, a decrease of -67.44%. That is a compound annual growth rate of -24.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 21.06M | -24.11% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 953.43B |
| Johnson & Johnson | 497.83B |
| AbbVie | 399.78B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 255.85B |
| Abbott Laboratories | 219.96B |